Skip to main content
Chemcon Speciality Chemicals Limited logo

Chemcon Speciality Chemicals Limited — Investor Relations & Filings

Ticker · CHEMCON ISIN · INE03YM01018 LEI · 254900W11B90JYLUAX92 BSE.NS Manufacturing
Open in API
Filings indexed 395 across all filing types
Latest filing 2026-05-26 Regulatory Filings
Country IN India
Listing BSE.NS CHEMCON

About Chemcon Speciality Chemicals Limited

https://cscpl.com/

Chemcon Speciality Chemicals Limited specializes in the manufacturing of specialized chemical products, primarily serving the pharmaceutical and oilfield sectors. The company's core product portfolio includes Hexamethyldisilazane (HMDS) and Chloromethyl Isopropyl Carbonate (CMIC), which are critical intermediates used in the synthesis of pharmaceutical ingredients, particularly for anti-retroviral drugs. Additionally, the company produces a range of inorganic bromides, such as Calcium Bromide, Zinc Bromide, and Sodium Bromide, which function as completion fluids in oil and gas exploration. Chemcon maintains a significant market position as a leading producer of HMDS globally. The organization operates advanced manufacturing facilities equipped with specialized reactors and distillation columns to ensure high purity standards and consistent quality across its chemical synthesis processes.

Recent filings

Filing Released Lang Actions
Annual Secretarial Compliance Report
Regulatory Filings Classification · 92% confidence The document is an “Annual Secretarial Compliance Report” issued by a practicing company secretary under SEBI Listing Regulations. It is a statutory attestation/certification of regulatory compliance rather than a financial report, AGM material, management change, dividend notice, etc. According to the rules, an officer certification or compliance certificate should be classified as a general regulatory filing (RNS).
2026-05-26 English
Investor Presentation - May 2026
Investor Presentation Classification · 92% confidence The document is a slide deck titled “Investor Presentation – May 2026” containing detailed financial performance highlights (Q4 & FY26 P&L, balance sheet, cash flow), strategic updates (acquisition, product lines), company overview, market presence, and forward‐looking statements. It was filed under SEBI Reg. 30 as an investor presentation and includes substantive charts and analysis. This matches the definition of an Investor Presentation (Code: IP).
2026-05-22 English
Investor Presentation
Investor Presentation Classification · 99% confidence The document is an official submission under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements. It encloses the “Investor Presentation” for May 2026 and contains slides (Safe Harbor, Q4 & FY26 Performance Highlights, financial statements, business overview, strategy, global presence, etc.). This is a detailed investor presentation, not a press release, earnings release, or full annual report. Therefore, it matches the definition of an Investor Presentation (Code: IP).
2026-05-22 English
Newspaper Publication
Report Publication Announcement Classification · 90% confidence The primary text is a company letter to stock exchanges notifying them that the Audited Financial Results for the quarter and year ended March 31, 2026 were published as a newspaper advertisement (with a copy attached) and are available on the company’s website. This is an announcement of the publication of a report (not the report itself), fitting the definition of a Report Publication Announcement (RPA).
2026-05-22 English
Copy of Newspaper Publication
Report Publication Announcement Classification · 95% confidence The document is a notice from Chemcon Speciality Chemicals Limited to BSE and NSE announcing that the audited financial results for the quarter and year ended March 31, 2026 were published in newspapers “in accordance with Regulation 47 ...” and that a copy of the advertisement is attached. It does not contain the actual financial statements but merely informs the exchange that the results have been published and provides an attachment. Under the “menu vs meal” rule, this is an announcement of a report, not the report itself.
2026-05-22 English
Reappointment of Cost Auditor and Internal Auditor
Regulatory Filings Classification · 85% confidence The document is an outcome of a Board Meeting notice filed under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It summarizes approvals (audited results, interim dividend, auditor appointments) and attaches auditors’ reports and declarations, but does not itself contain the full financial statements as a standalone annual or interim report. It is a regulatory announcement/compliance filing rather than the report itself or a change of management, dividend‐only notice, or other specific category. Therefore it falls under the general “Regulatory Filings” category (RNS).
2026-05-21 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.